Cellular and genetic factors involved in the difference between brown norway and lewis rats to develop respectively type-2 and type-1 immune-mediated diseases

Immunological Reviews

Volumn 184, Issue , 2001, Pages 145-160

  Fournié, Gilbert J ^a   Cautain, Bastien ^a   Xystrakis, Emmanuel ^a   Damoiseaux, Jan ^b   Lagrange, Magali Mas Dominique ^a   Bernard, Isabelle ^a   Subra, Jean François ^a   Pelletier, Lucette ^a   Druet, Philippe ^a   Saoudi, Abdelhadi ^a,c  

^a INSERM   (France)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c CHU PURPAN   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD45 ANTIGEN; CD8 ANTIGEN; GOLD SALT; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 4; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; AUTOIMMUNE DISEASE; AUTOIMMUNITY; CHROMOSOME 10; CHROMOSOME 20; CHROMOSOME 9; GENETIC SUSCEPTIBILITY; HEREDITY; IMMUNOLOGICAL TOLERANCE; MAJOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ASSAY; RAT; REVIEW; STRAIN DIFFERENCE; T LYMPHOCYTE SUBPOPULATION; TH1 CELL;

ANIMALS; ANTIGENS, CD45; DISEASE SUSCEPTIBILITY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURITIS, AUTOIMMUNE, EXPERIMENTAL; RATS; RATS, INBRED BN; RATS, INBRED LEW; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS;

EID: 0035707771     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065x.2001.1840114.x     Document Type: Review

References (125)

1. + T cells in the pathogenesis of organ-specific autoimmune diseases
2. Functional diversity of T helper lymphocytes
3. The TH1/TH2 concept and its relevance to renal disorders and transplantation immunity
4. Genetic control of the development of experimental allergic encephalomyelitis in rats: Separation of MHC and non-MHC effects
5. TH1 and TH2 lymphocytes in autoimmunity
6. TH1 and TH2 dependent cytokines in experimental autoimmunity and immune reactions induced by chemicals
7. Mercuric chloride, a chemical responsible for T helper cell (Th)2-mediated autoimmunity in brown Norway rats, directly triggers T cells to produce interleukin-4
8. Th1 and Th2 cells: Different patterns of lymphokine secretion lead to different functional properties
9. + T cells and their role in the induction and prevention of autoimmunity
10. + T cells
11. Helper activity for immunoglobulin synthesis of T helper type 1 (Th1) and Th2 human T cell clones: The help of Th1 clones is limited by their cytolytic capacity
12. Cytokines induce the development of functionally heterogeneous T helper cell subsets
13. The expanding universe of T-cell subsets: Th1, Th2 and more
14. Effects of IL-12 on helper T cell-dependent immune responses in vivo
15. Interleukin-12 induces interferon-γ dependent switching of IgG alloantibody subclass
16. TH2 activated cells prevent experimental autoimmune uveoretinitis, a TH1-dependent autoimmune disease
17. - T cells from T cell receptor transgenic mice
18. A role for non-MHC genetic polymorphism in susceptibility to spontaneous autoimmunity
19. The regulation of immunity to Leishmania major
20. Natural killer cell stimulatory factor (interleukin 12, IL-12) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells
21. Helper T cell subsets: Phenotype, function and the role of lymphokines in regulating their development
22. Reciprocal control of T helper cell and dendritic cell differentiation
23. Prevention of experimental allergic encephalomyelitis in rats by targeting autoantigen to B cells: Evidence that the protective mechanism depends on changes in the cytokine response and migratory properties of the autoantigen-specific T cells
24. Genetic variation in the stress response: Susceptibility to experimental allergic encephalomyelitis and implications for human inflammatory disease
25. Pregnancy impairs resistance of C57BL/6 mice to Leishmania major infection and causes decreased antigen-specific IFN-γ response and increased production of T helper 2 cytokines
26. + T cells
27. + T cell phenotype development in an αβ-TCR-transgenic mouse model
28. + T cell responses: The alternative approaches
29. + T cells by antigenic peptides altered for TCR binding
30. - T cell differentiation
31. MRC OX-22, a monoclonal antibody that labels a new subset of T lymphocytes and reacts with the high molecular weight form of the leukocyte-common antigen
32. + T-cell subsets in the rat
33. + T cell subset that inhibits this autoimmune potential
34. - thymocytes
35. + T cells in man form two distinct subpopulations, defined by their expression of isoforms of the leucocyte common antigen, CD45
36. + regulatory cells that control intestinal inflammation
37. CTLA-4 blockade enhances clinical disease and cytokine production during experimental allergic encephalomyelitis
38. CTLA-4: A negative regulator of autoimmune disease
39. Cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) regulates the unfolding of autoimmune diabetes
40. + T cells: Their activation and effector functions
41. Generation of polarized antigen-specific CD8 effector populations: Reciprocal action of interleukin (IL)-4 and IL-12 in promoting type 2 versus type 1 cytokine profiles
42. TH2 cells in systemic autoimmunity: Insights from allogeneic diseases and chemically-induced autoimmunity
43. Induction of IgE synthesis and potentiation of anti-ovalbumin IgE antibody response by HgCl2 in the rat
44. Immune-type glomerulonephritis induced in the Brown-Norway rat with mercury-containing pharmaceutical products
45. 2 in Brown-Norway rats. I. Production of monoclonal antibodies
46. Mercuric chloride-induced vasculitis in the Brown Norway rat: αβ T cell-dependent and -independent phases: Role of the mast cell
47. Inflammatory polyarthritis induced by mercuric chloride in the Brown Norway rat
48. Th1/Th2 cytokine gene expression after mercuric chloride in susceptible and resistant rat strains
49. 2-induced autoimmunity
50. Interleukin-4 gene expression in mercury-induced autoimmunity
51. 2 induces non specific immunosuppression in LEW rats
52. Down-modulation of Heymann's nephritis by mercuric chloride
53. 2-induced downmodulation of the disease
54. Experimental gold-induced autoimmunity
55. Th2 and Th1 autoreactive anti-class II cell lines in the rat suppress or induce autoimmunity
56. Self-reactive anti-class II T helper type 2 cell lines derived from gold salt-injected rats trigger B cell polycolonal activation and transfer autoimmunity in CD8-depleted normal syngeneic recipients
57. + antiergotypic cells in Lewis rats
58. + T cell lines
59. Gold is a T cell polyclonal activator in BN and LEW rats but favors IL-4 expression only in autoimmune prone BN rats
60. Multiple sclerosis: A coordinated immunological attack against myelin in the central nervous system
61. Analysis of autoimmune demyelination: Its impact upon multiple sclerosis
62. Experimental autoimmune encephalomyelitis in rodents as a model for human demyelinating disease
63. Oral tolerance to myelin basic protein and natural recovery from experimental autoimmune encephalomyelitis are associated with downregulation of inflammatory cytokines and differential upregulation of transforming growth factor-β, interleukin 4 and prostaglandin
64. Interferon γ, interleukin 4 and transforming growth factor β in experimental autoimmune encephalomyelitis in Lewis rats: Dynamics of cellular mRNA expression in the central nervous system and lymphoid cells
65. Cytokines in relapsing experimental autoimmune encephalomyelitis in DA rats: Persistent mRNA expression of proinflammatory cytokines and absent expression of interleukin-10 and transforming growth factor-β
66. Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma
67. Encephalithogenic T cells in the B10.PL model of experimental allergic encephlomyelitis (EAE) are of the Th-1 lymphokine subtype
68. Self-antigen-induced Th2 responses in experimental allergic encephalomyelitis (EAE)-resistant mice
69. Myelin basic protein-specific T helper (Th2) cells cause experimental autoimmune encephalomyelitis in immunodeficient hosts rather than protect them from the disease
70. Genetic control of susceptibility to experimental allergic encephalomyelitis and the Ag-B locus of rats
71. Association between susceptibility to experimental allergic encephalomyelitis and the major histocompatibility system in congenic rat strains
72. The major histocompatibility complex influences myelin basic protein 63-88-induced T cell cytokine profile and experimental autoimmune encephalomyelitis
73. Protective influences on experimental autoimmune encephalomyelitis by MHC class I and class II alleles
74. Essential role of TGP-β in the natural resistance to experimental allergic encephalomyelitis in rats
75. Characterization of latent TGF-β activation by murine peritoneal macrophages
76. Pathological mechanisms in experimental autoimmune myasthenia gravis. I. Immunogenicity of syngeneic muscle acetylcholine receptor and quantitative extraction of receptor and antibody-receptor complexes from muscles of rats with experimental autoimmune myasthenia gravis
77. Experimental autoimmune myasthenia gravis and myasthenia gravis: Biochemical and immunochemical aspects
78. Pathological mechanisms in experimental autoimmune myasthenia gravis. II. Passive transfer of experimental autoimmune myasthenia gravis in rats with anti-acetylcholine receptor antibodies
79. Passive transfer of experimental myasthenia gravis via antigenic modulation of acetylcholine receptor
80. Anti-acetylcholine receptor antibodies directed against the α-bungarotoxin binding site induce a unique form of experimental myasthenia
81. C5 gene influences the development of murine myasthenia gravis
82. Resistance to experimental autoimmune myasthenia gravis in genetically inbred rats. Association with decreased amounts of in situ acethylcholine receptor-antibody complexes
83. Age-related susceptibility to experimental autoimmune myasthenia gravis: Immunological and electrophysiological aspects
84. Experimental autoimmune myasthenia gravis may occur in the context of a polarized Th1- or Th2-type immune response in rats
85. Myasthenia gravis-like syndrome induced by expression of interferon γ in the neuromuscular junction
86. Interferon γ (IFN-γ) is necessary for the genesis of acethylcholine receptor-induced clinical experimental autoimmune myasthenia gravis in mice
87. The Th2 cytokine IL-4 is not involved for the progression of antibody-dependent autoimmune myasthenia gravis
88. IL-12 is involved in the induction of experimental autoimmune myasthenia gravis, an antibody-mediated disease
89. Role of complement in the pathogenesis of experimental autoimmune myasthenia gravis
90. Inhibition of acute passive transfer experimental autoimmune myasthenia gravis with Fab antibody to complement C6
91. Immunogenetics of experimental autoimmune myasthenia gravis
92. Rat Immunoglobulins
93. Classes and subclasses of rat immunoglobulins: Interaction with the complement system and with staphylococcal protein A
94. Acetylcholine receptor antibody in myasthenia gravis: Predominance og IgG subclasses 1 and 3
95. - thymocytes are phenotypically heterogeneous on activation
96. A dominant role for the thymus and MHC genes in determining the peripheral CD4/CD8 T cell ratio in the rat
97. Negative selection of lymphocytes
98. Positive selection of thymocytes
99. + T cells
100. Clonal deletion induced by either radioresistant thymic host cells or lymphohemopoietic donor cells at different stages of class I-restricted T cell ontogeny
101. Prostaglandin E2 differentially modulates cytokine secretion profiles of human T helper lymphocytes
102. Prostaglandin E2 inhibits production of Th1 lymphokines but not of Th2 lymphokines
103. Nitric oxide suppresses IFN-γ production in the spleen of mercuric chloride-exposed Brown-Norway rats
104. + T cells
105. + T cell subset activation
106. How the MHC selects Th1/Th2 immunity
107. Altered Th1/Th2 balance associated with non-major histocompatibility complex genes in collagen-induced arthritis in resistant and non-resistant rat strains
108. A dominant role for non-MHC gene effects in susceptibility to cyclosporin A (CsA)-induced autoimmunity
109. Genetic study of gold-salt-induced immune disorders in the rat
110. Serum IgE concentration and other immune manifestations of treatment with gold salts are linked to the MHC and IL4 regions in the rat
111. low CD4 T cells in rats is intrinsic to bone marrow-derived cells and is genetically controlled
112. Post-thymic T-cell development in the rat
113. The physiological role of regulatory T cells in the prevention of autoimmunity: The function of the thymus in the generation of the regulatory T cell subset
114. Single expression of CD45RC and RT6 in correlation with T-helper 1 and T-helper 2 cytokine patterns in the rat
115. + naive CD4 T cells
116. CD45RC isoforms define two types of CD4 memory T cells, one of which depends on persisting antigen
117. Rat chromosome 9 bears a major susceptibility locus for IgE response
118. Computational and biological analysis of 680 kb of DNA sequence from the human 5q31 cytokine gene cluster region
119. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations
120. Evidence for a locus regulating total serum IgE levels mapping to chromosome 5
121. Tpm1, a locus controlling IL-12 responsiveness, acts by a cell-autonomous mechanism
122. A genome-wide search identifies two susceptibility loci for experimental autoimmune encephalomyelitis on rat chromosomes 4 and 10
123. Regulation of disease susceptibility: Decreased prevalence of IgE-mediated allergic disease in patients with multiple sclerosis
124. Graft-versus-host disease after brown Norway-to-Lewis and Lewis-to-Brown Norway rat intestinal transplantation under FK506